Upon escaping the unfavorable condition, GAS5 expression is decreased and the “brakes” are released allowing CD133+ cells to draw upon the stored metabolites in biosynthetic pathways and jumpstart the processes required for active proliferation resulting in an aggressive tumor. Here, GAS5 is linked to neoplasm.